Roy D Ary, MD | |
531 Asbury Cir, Atlanta, GA 30322-1006 | |
(404) 778-5975 | |
(404) 778-2630 |
Full Name | Roy D Ary |
---|---|
Gender | Male |
Speciality | Addiction Medicine |
Experience | 32 Years |
Location | 531 Asbury Cir, Atlanta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639100712 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QA0401X | Family Medicine - Addiction Medicine | MD.41888 (Alabama) | Primary |
207P00000X | Emergency Medicine | 48872 (Georgia) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pathway Healthcare Alabama Llc | 1658653548 | 7 |
News Archive
At a time when a growing number of men with prostate cancer considered "low risk" are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease.
Repetitive training that simulates everyday leg function can help people walk more easily after stroke, according to a new review of studies.
Post-operative cognitive dysfunction (POCD), a condition mostly observed in older patients following surgery under general anesthesia, is characterized by impaired memory and concentration. The impairment may be temporary or permanent and incapacitating.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 5 days ago
Entity Name | Pathway Healthcare Alabama Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053855122 PECOS PAC ID: 1658653548 Enrollment ID: O20170130001952 |
News Archive
At a time when a growing number of men with prostate cancer considered "low risk" are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease.
Repetitive training that simulates everyday leg function can help people walk more easily after stroke, according to a new review of studies.
Post-operative cognitive dysfunction (POCD), a condition mostly observed in older patients following surgery under general anesthesia, is characterized by impaired memory and concentration. The impairment may be temporary or permanent and incapacitating.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Roy D Ary, MD 1000 Urban Center Dr, Ste 600, Vestavia, AL 35242-2584 Ph: (205) 208-9312 | Roy D Ary, MD 531 Asbury Cir, Atlanta, GA 30322-1006 Ph: (404) 778-5975 |
News Archive
At a time when a growing number of men with prostate cancer considered "low risk" are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease.
Repetitive training that simulates everyday leg function can help people walk more easily after stroke, according to a new review of studies.
Post-operative cognitive dysfunction (POCD), a condition mostly observed in older patients following surgery under general anesthesia, is characterized by impaired memory and concentration. The impairment may be temporary or permanent and incapacitating.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
› Verified 5 days ago
Fidelia O Osinubi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3885 Princeton Lakes Way, Suite 402, Atlanta, GA 30331 Phone: 404-349-0496 Fax: 404-349-6081 | |
Theresa R Jacobs, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 868 York Ave Sw, Atlanta, GA 30310 Phone: 404-752-1400 Fax: 404-758-0740 | |
David M Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1046 Ridge Ave Sw, Atlanta, GA 30315 Phone: 404-688-1350 Fax: 404-564-6734 | |
Tony Serrano-padin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1701 Hardee Ave. Sw, Bldg 125, Fort Mcpherson - Army Health Clinic, Atlanta, GA 30330 Phone: 404-464-0389 | |
Dr. Bhavi Patel Purohit, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Westview Dr Sw, Atlanta, GA 30310 Phone: 404-756-1230 Fax: 404-752-8682 | |
Dr. Edmond Shih, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5461 Buford Hwy Ne, Atlanta, GA 30340 Phone: 770-457-5556 Fax: 770-457-7776 | |
Zahidul Islam Chowdhury, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 N Highland Ave Ne, Suite F, Atlanta, GA 30307 Phone: 404-658-9840 Fax: 404-658-9846 |